Triple board-certified in internal medicine, hematology and medical oncology, Dr. Mohamad Cherry is medical director of Hematology at Atlantic Health System. He joins Atlantic Hematology Oncology from the University of Oklahoma Health Sciences Center's Stephenson Cancer Center, bringing years of clinical knowledge and expertise.With specialty training from some of the nation's most skilled clinicians, Dr. Cherry attained some of his clinical training at the leukemia department at MD Anderson and his fellowship in hematology/oncology from the University of Oklahoma Health Sciences Center's Stephenson Cancer Center. He performed two residencies - an internal medicine residency at Staten Island University Hospital and a laboratory medicine residency at the American University of Beirut Medical Center in Lebanon. Previously, Dr. Cherry attained his medical degree at Lebanese University and performed his internship at Sacre Coeur Hospital-Lebanese University. He also earned a master of science degree in clinical and translational research from University of Oklahoma College of Public Health.Dr. Cherry remains on staff as clinical associate professor of hematology/oncology at University of Oklahoma Health Sciences Center's Stephenson Cancer Center. He is also the director of its hematology/oncology fellowship program and co-chairs the Academy of Teaching Scholars Faculty Development, Education and Mentoring Committee. Other administrative roles include co-chair of the leukemia working group at the Sarah Cannon Research Institute Blood Cancer Consortium.As a principal investigator of multiple clinical trials, Dr. Cherry has performed groundbreaking research in niche areas that include epigenetics and development of new therapeutics in relapsed and refractory blood cancers. He has developed teaching materials and book chapters, and has lectured both nationally and internationally.Dr. Cherry continues to serves as a mentor and an advisor to fellows, residents and medical students. He contributes to continuing education, public health, and professional development, and has won awards and funding for both his research and his clinical pursuits. Dr. Cherry is rated as an Advanced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). His top areas of expertise are Acute Myeloid Leukemia (AML), Non-Hodgkin Lymphoma, Acute Myeloblastic Leukemia without Maturation, Midline Lethal Granuloma, and Bone Marrow Aspiration.

Sophie Morse is a Hematologist Oncology specialist and a Hematologist in Summit, New Jersey. Dr. Morse is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). Her top areas of expertise are Familial Colorectal Cancer, Colorectal Cancer, Lynch Syndrome, and Familial Pancreatic Cancer.

Ahmed Galal is a Hematologist and an Oncologist in Morristown, New Jersey. Dr. Galal is rated as an Advanced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). His top areas of expertise are Mantle Cell Lymphoma (MCL), Diffuse Large B-Cell Lymphoma (DLBCL), Large-Cell Immunoblastic Lymphoma, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Galal is currently accepting new patients.

Dr. Charles Farber is a board-certified, fellowship-trained oncologist at Atlantic Hematology Oncology located at Morristown Medical Center’s Carol G. Simon Cancer Center. He maintains a broad-based practice, yet focuses on benign and malignant hematology. Dr. Farber also serves as medical director of Oncology Research Network Development for Atlantic Health System. In this role, he works with the system’s Breakthrough Oncology Accelerator partners, Translational Genomics Research Institute (TGen) and OriginCV, to expand cancer research at Morristown Medical Center and throughout Atlantic Health System. This partnership ensures that patients have access to the newest and most exciting drugs and technologies through clinical trials. In addition to receiving multiple Patient’s Choice Awards, Dr. Farber has been recognized as a Top Doctor in the New York Metro Area, and listed in Inside Jersey magazine’s Top Doctors, and Consumers Research Council’s Guide to America’s Top Oncologists. He is regarded by colleagues and patients as a knowledgeable, compassionate and devoted physician and has been providing expert care to the Morristown community for more than 20 years. Dr. Farber attended New York University School of Medicine for his medical degree and performed his residency and fellowship at Weill Cornell Medical Center. He also earned a master’s degree and PhD from New York University’s Graduate School of Arts and Sciences. Dr. Farber chairs Morristown Medical Center’s cancer subcommittee for adolescents and young adults and serves as secretary and treasurer of the Oncology Society of New Jersey. He was former chief of the division of Hematology/Oncology at Morristown Medical Center from 2007 to 2011. Dr. Farber serves as a clinical assistant professor at Rutgers and at the Cancer Institute of New Jersey. His research has been published in the Journal of the American Nutraceutical Association, the New England Journal of Medicine and the National Cancer Institute’s Clinical Trial Directory. Dr. Farber is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Non-Hodgkin Lymphoma, Follicular Lymphoma, and Bone Marrow Aspiration.

Dr. Mark Widmann is chief of Thoracic Surgery at Morristown Medical Center and leads Atlantic Medical Group’s North Jersey Thoracic Surgical Associates. Board certified in thoracic surgery, Dr. Widmann offers expert subspecialty surgical care to patients with benign and malignant disorders of the lung, mediastinum, pleura, esophagus and chest wall. He has expertise in state-of-the-art, minimally-invasive techniques and has led the programs development of Video-Assisted Thoracic Surgery (VATS) and other endoscopic/laparoscopic approaches to treat conditions such as cancer, infection, pneumothorax and swallowing disorders.With a commitment to clinical excellence, Dr. Widmann leads the section of thoracic surgery at Morristown Medical Center and has been surgical director of the Lung Cancer Program at Atlantic Health’s Carol G. Simon Cancer Center since 2000. Dr. Widmann graduated magna cum laude from Duke University and went on to pursue his medical degree at Yale University School of Medicine. His post-graduate training includes NIH sponsored research fellowships in Cardiovascular disease at Yale and the University of Iowa Hospitals. He performed his residency training in general surgery at Yale-New Haven Hospital in New Haven, CT and cardiothoracic residency training at the University of Iowa Hospitals & Clinics in Iowa City, IA.Committed to resident education, Dr. Widmann serves as an assistant clinical professor of surgery at Columbia University College of Physicians and Surgeons in New York. He is a member of the Society of Thoracic Surgeons and a fellow of the American College of Surgeons and the American College of Chest Physicians and former president of the NJ Society of Thoracic Surgeons. Dr. Widmann is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). His top areas of expertise are Fibrosing Mediastinitis, Pleuropulmonary Blastoma, Lung Nodules, Thymectomy, and Endoscopy.

Israel Grossman is a Hematologist Oncology specialist and a Hematologist in Livingston, New Jersey. Dr. Grossman is rated as a Distinguished provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). His top areas of expertise are Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL), Plasmacytoma, Hodgkin Lymphoma, Marginal Zone Lymphoma (MZL), and Bone Marrow Aspiration. Dr. Grossman is currently accepting new patients.

Stacey Kalambakas is a Pediatric Hematologist Oncology provider in Morristown, New Jersey. Dr. Kalambakas is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). Her top areas of expertise are Marginal Zone Lymphoma (MZL), Leukemia, and Immune Thrombocytopenic Purpura (ITP).

Dr. Sonyo Shin is an esteemed attending hematologist/oncologist at Advanced Care Oncology and Hematology Associates (ACOHA), a distinguished part of Atlantic Medical Group (AMG). With over 20 years of dedicated experience in the field, she is deeply committed to delivering patient-centered care in both hematology and oncology.Dr. Shin is board-certified in internal medicine, oncology, and hematology by the American Board of Internal Medicine. Her extensive expertise encompasses the treatment of a wide range of malignancies, including lymphoma, lung cancer, and chronic leukemia. She has been instrumental in developing and leading multidisciplinary breast cancer clinics, ensuring a comprehensive approach to patient care.In addition to her clinical practice, Dr. Shin is actively involved in clinical trials, contributing to the advancement of cancer research. She is also passionate about education, mentoring medical residents and students to foster the next generation of healthcare professionals. Her commitment to excellence in patient care and education underscores her role as a leader in the field of hematology and oncology. Dr. Shin is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). Her top areas of expertise are Paget Disease of the Breast, Familial Colorectal Cancer, Lung Adenocarcinoma, and Small Cell Lung Cancer (SCLC).

Jeanette Kovtun is an Internal Medicine provider in Florham Park, New Jersey. Dr. Kovtun is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). Her top areas of expertise are Mesothelioma, Iron Deficiency Anemia, Childhood Iron Deficiency Anemia, and Thrombocytopenia. Dr. Kovtun is currently accepting new patients.

Anita Kumar is a Hematologist and an Oncologist in Basking Ridge, New Jersey. Dr. Kumar has been practicing medicine for over 18 years and is rated as an Advanced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). Her top areas of expertise are Mantle Cell Lymphoma (MCL), Gastric Lymphoma, Non-Hodgkin Lymphoma, Follicular Lymphoma, and Bone Marrow Aspiration. Dr. Kumar is currently accepting new patients.

Jason Levitz is a Hematologist and an Oncologist in Denville, New Jersey. Dr. Levitz is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). His top areas of expertise are Polycythemia Vera, Colorectal Cancer, Familial Colorectal Cancer, Paget Disease of the Breast, and Bone Marrow Aspiration. Dr. Levitz is currently accepting new patients.

Fazal Bari is a Hematologist and an Oncologist in Mountain Lakes, New Jersey. Dr. Bari is rated as an Advanced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). His top areas of expertise are Paget Disease of the Breast, Childhood Iron Deficiency Anemia, Iron Deficiency Anemia, and Colorectal Cancer. Dr. Bari is currently accepting new patients.

Audrey Hamilton is an Oncologist in Denville, New Jersey. Dr. Hamilton is rated as an Advanced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). Her top areas of expertise are Non-Hodgkin Lymphoma, Follicular Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), and Hodgkin Lymphoma.

Usman Shah is a Hematologist and an Oncologist in Summit, New Jersey. Dr. Shah is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). His top areas of expertise are Familial Colorectal Cancer, Colorectal Cancer, Familial Pancreatic Cancer, Non-Hodgkin Lymphoma, and Bone Marrow Aspiration. Dr. Shah is currently accepting new patients.

Michael Scoppetuolo is a Hematologist Oncology specialist and an Oncologist in Livingston, New Jersey. Dr. Scoppetuolo is rated as an Advanced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). His top areas of expertise are Breast Cancer, Paget Disease of the Breast, Colorectal Cancer, and Familial Colorectal Cancer. Dr. Scoppetuolo is currently accepting new patients.

Dr. Saksena is a dynamic, clinically oriented, hematologist/oncologist with several years of experience in the treatment of various cancers and blood disorders. She is triple board-certified in internal medicine, medical oncology, and hematology by the American Board of Internal Medicine. Her strong medical back- ground combined with her passion to build meaningful patient-centered relationships enables her to deliver leading-edge care in a highly personalized manner. She practices comprehensive cancer care, with direct access to the latest clinical trials, and works closely with surgeons, radiation oncologists, genetic counselors, nurses, social workers and dietitians.Dr. Saksena attended Lehigh University, where she obtained a bachelor of science degree in behavioral neuroscience. She earned her medical degree at Jefferson Medical College, part of Thomas Jefferson University in Philadelphia, and then completed her hematology/oncology fellowship at Rutgers Cancer Institute of New Jersey (CINJ) & Robert Wood Johnson University Hospital in New Brunswick.During her education, Dr. Saksena received a number of honors, awards and scholarships for her clinical work, leadership roles, and research. She served as chief fellow of hematology oncology while at Rutgers CINJ, the state’s only National Cancer Institue-designated cancer center. Dr. Saksena also speaks Hindi, Gujarati and conversational Spanish, and is committed to community outreach through advocacy groups and as a liaison of the American Medical Women’s Association.Dr. Saksena is a member of Atlantic Medical Group, and is a participating provider in the Atlantic Accountable Care Organization. Dr. Saksena is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Familial Colorectal Cancer, and Primitive Neuroectodermal Tumor (PNET).

Kevin David is an Oncologist and a Hematologist in Basking Ridge, New Jersey. Dr. David is rated as a Distinguished provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). His top areas of expertise are Non-Hodgkin Lymphoma, Hodgkin Lymphoma, B-Cell Lymphoma, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. David is currently accepting new patients.

Naveed Jan is a Hematologist and an Oncologist in Denville, New Jersey. Dr. Jan is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). His top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Thrombocytopenia, and Vitamin B12 Deficiency. Dr. Jan is currently accepting new patients.

Audrey Kalan is a Nurse Practitioner in Basking Ridge, New Jersey. Ms. Kalan is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). Her top areas of expertise are Smoldering Multiple Myeloma, Small Lymphocytic Lymphoma (SLL), Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL), and Marginal Zone Lymphoma (MZL). Ms. Kalan is currently accepting new patients.

Yong Kwon is a Gastroenterologist in Berkeley Heights, New Jersey. Dr. Kwon is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). His top areas of expertise are Bile Duct Obstruction, Ulcerative Colitis, Gastroesophageal Reflux Disease (GERD), Colonoscopy, and Gastrectomy.